Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Discovery Platform
Sponsor : Zealand Pharma
Deal Size : $2,500.0 million
Deal Type : Collaboration
Zealand Pharma, OTR Therapeutics Collaborate on Metabolic Treatment
Details : The collaboration aims to advance the development of a new treatment for metabolic diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : $20.0 million
December 11, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Discovery Platform
Sponsor : Zealand Pharma
Deal Size : $2,500.0 million
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : True Light Capital
Deal Size : $100.0 million
Deal Type : Series A Financing
Otr Therapeutics Raises $100 Million in Series A Financing for Global Therapies
Details : The Series A financing will support the development of an undisclosed product in the field of immunology & inflammation.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 04, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : True Light Capital
Deal Size : $100.0 million
Deal Type : Series A Financing
Reset All
